Conversion of Recent-Onset Atrial Fibrillation by a Single Oral Dose of Pilsicainide ( Pilsicainide Suppression Trial on Atrial Fibrillation)

The efficacy and safety of a single oral dose of 150 mg pilsicainide, a new class Ic antiarrhthymic drug, in converting recent-onset atrial fibrillation to sinus rhythm were evaluated.

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 1996-09, Vol.78 (6), p.694-697
Main Authors: Atarashi, Hirotsugu, Inoue, Hiroshi, Hiejima, Kazumasa, Hayakawa, Hirokazu
Format: Article
Language:English
Subjects:
Drug therapy
Medical research
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The efficacy and safety of a single oral dose of 150 mg pilsicainide, a new class Ic antiarrhthymic drug, in converting recent-onset atrial fibrillation to sinus rhythm were evaluated.
ISSN:0002-9149
1879-1913
DOI:10.1016/S0002-9149(96)00401-8